Frontlight ResearchEarly access
Active, not recruitingNo phase
AED 3 Post-Approval Study
Key facts
- Who runs it
- Zoll Medical Corporation
- Where
- Buffalo and Latham, United StatesSee the 2 sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 38 people enrolled
- Started
- 30 Mar 2021
- Expected to end
- 28 Feb 2029
- Type of study
- Interventional
- Treatments tested
- AED 3 with Uni-padz
- Record updated
- 17 August 2025
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Suspected out-of-hospital cardiac arrest
- Use of ZOLL AED 3 public-access defibrillator (running software v.1.03.602 or newer (US) or v. 6.03.006 or newer(OUS)) with Uni-padz III
- Unconsciousness
- Absence of breathing
- Absence of pulse and other signs of circulation
Who cannot take part
- No evidence of cardiac arrest
- Pre-existing Do Not Attempt Resuscitation (DNAR) orders
Where in United States
- University at BuffaloBuffalo, United States
- Colonie EMSLatham, United States
About the trial
What the trial wants to find out
Demonstrate appropriate CPR sensor placement on pediatric and adult patients and demonstrate delivery of appropriate energy level of shocks to pediatric and adult patients.
The group in the trial
- AED 3 with Uni-padzOther group
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Post-Approval Study for AED 3 With Uni-padz
- Record updated
- 17 August 2025